Clinical Trial Update: A Prospective Study of Plasma Genotyping as a Noninvasive Biomarker for Genotype-directed Cancer Care

View source ↗

Summary

This entry describes a prospective clinical trial evaluating plasma genotyping as a noninvasive biomarker to guide genotype-directed cancer care, currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Non-small Cell Lung Cancer

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: NSCLC, Melanoma | Status: RECRUITING